Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal

Robert Edfors1,2, Anders Sahlén1,2,3, Karolina Szummer1,2

  • 1Department of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden.

Insights

Ticagrelor use in acute myocardial infarction (MI) patients showed a lower risk of death, MI, or stroke compared to clopidogrel across all estimated glomerular filtration rate (eGFR) levels. However, ticagrelor was associated with increased bleeding risk, particularly in patients with reduced eGFR.

Area of Science:

  • Cardiology
  • Pharmacology
  • Nephrology

Background:

  • Acute myocardial infarction (MI) management often involves P2Y12 inhibitors like ticagrelor and clopidogrel.
  • Patient outcomes may vary based on renal function, specifically estimated glomerular filtration rate (eGFR).

Purpose of the Study:

  • To analyze the comparative effectiveness and safety of ticagrelor versus clopidogrel in acute MI survivors.
  • To stratify outcomes based on patient estimated glomerular filtration rate (eGFR) levels.

Main Methods:

  • Utilized data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease registry.
  • Employed adjusted Cox proportional hazards models to assess the association between ticagrelor and clopidogrel with composite outcomes (death, MI, stroke) and bleeding rehospitalization at one year.
  • Stratified analyses were performed across eGFR categories: >60, 30-60, and <30 mL/min/1.73m².

Main Results:

  • In a cohort of 45,206 MI patients, ticagrelor was associated with a lower adjusted 1-year risk of death, MI, or stroke compared to clopidogrel across all eGFR strata (eGFR>60: HR 0.87; eGFR 30-60: HR 0.82).
  • Ticagrelor use was linked to a higher risk of bleeding rehospitalization, with a more pronounced effect observed in patients with eGFR <30 mL/min/1.73m² (HR 1.79).
  • No significant interaction was found between treatment and eGFR for either the composite outcome or bleeding risk.

Conclusions:

  • Ticagrelor demonstrates a reduced risk of major adverse cardiovascular events compared to clopidogrel in acute MI patients, irrespective of renal function.
  • Clinicians should exercise caution regarding increased bleeding risk with ticagrelor, especially in patients with severely impaired renal function (eGFR <30 mL/min/1.73m²).
  • The findings support individualized treatment decisions considering both efficacy and bleeding risk in MI patients with varying degrees of renal impairment.
Abstract

Related Concept Videos

Stratified Sampling Method01:16

Stratified Sampling Method

Sampling is a technique to select a portion (or subset) of the larger population and study that portion (the sample) to gain information about the population. The sampling method ensures that samples are drawn without bias and accurately represent the population. Because measuring the entire population in a study is not practical, researchers use samples to represent the population of interest.
To choose a stratified sample, divide the population into groups called strata and then take a...
15.5K
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
457
Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
11.0K
Outcomes of Glycolysis01:13

Outcomes of Glycolysis

Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
107.7K
Classification of Epithelial Tissues: Stratified Epithelium01:29

Classification of Epithelial Tissues: Stratified Epithelium

Stratified epithelium consists of several stacked layers of cells. They provide the durability to withstand constant physical and chemical attacks. Stratified epithelium is named after the shape of the most apical layer of cells. Stratified squamous epithelium is the most common type found in the human body. In this tissue, the apical cells are squamous, whereas the basal layer contains either columnar or cuboidal cells. The basal cells divide to form new daughter cells, which gradually become...
13.1K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
485